(Q36099424)

12 August 2017

1 reference

title

Novel therapies in transplantation (English)

1 reference

12 August 2017

Anamaria Jorga

1

1 reference

12 August 2017

Atholl Johnston

series ordinal

2

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 March 2005

1 reference

Expert Opinion on Investigational Drugs

12 August 2017

published in

1 reference

12 August 2017

volume

14

1 reference

12 August 2017

issue

3

1 reference

12 August 2017

page(s)

295-304

1 reference

Immunosuppressants in advanced clinical development for organ transplantation and selected autoimmune diseases

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.3.295

The role of T-cell costimulatory activation pathways in transplant rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.3.295

The impact of mycophenolate mofetil dosing patterns on clinical outcome after renal transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.3.295

Enteric-coated mycophenolate sodium can be safely administered in maintenance renal transplant patients: results of a 1-year study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.3.295

ISA(TX)247: a novel calcineurin inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.3.295

Compared with cyclosporine, ISATX247 significantly prolongs renal-allograft survival in a nonhuman primate model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.3.295

Everolimus and reduced-exposure cyclosporine in de novo renal-transplant recipients: a three-year phase II, randomized, multicenter, open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.3.295

RAD in de novo renal transplantation: comparison of three doses on the incidence and severity of acute rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.3.295

Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.3.295

Exposure-response relationships for everolimus in de novo kidney transplantation: defining a therapeutic range

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.3.295

Update on pharmacokinetic/pharmacodynamic studies with FTY720 and sirolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.3.295

Pharmacodynamics of single doses of the novel immunosuppressant FTY720 in stable renal transplant patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.3.295

Pharmacodynamics, pharmacokinetics, and safety of multiple doses of FTY720 in stable renal transplant patients: a multicenter, randomized, placebo-controlled, phase I study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.3.295

Effects of the malononitrilamide FK778 on immune functions in vitro in whole blood from non-human primates and healthy human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.3.295

Immunosuppression with FK778 and mycophenolate mofetil in a rat cardiac transplantation model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.3.295

Synergistic effects of malononitrilamides (FK778, FK779) with tacrolimus (FK506) in prevention of acute heart and kidney allograft rejection and reversal of ongoing heart allograft rejection in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.3.295

Significant prolongation of renal allograft survival by delayed combination therapy of FK778 with tacrolimus in nonhuman primates1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.3.295

What's in the pipeline? New immunosuppressive drugs in transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.3.295

A prospective randomized multicenter study of tacrolimus in combination with sirolimus in renal-transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.3.295

Daclizumab induction, tacrolimus, mycophenolate mofetil and steroids as an immunosuppression regimen for primary kidney transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.3.295

Present experience with Campath-1H in organ transplantation and its potential use in pediatric recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.3.295

Campath-1H in renal transplantation: The University of Wisconsin experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.3.295

The use of Campath-1H as induction therapy in renal transplantation: preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.3.295

Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.3.295

Preliminary experience with campath 1H (C1H) in intestinal and liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.3.295

Preliminary experience with alemtuzumab (Campath-1H) and low-dose tacrolimus immunosuppression in adult liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.3.295

Alemtuzumab (Campath-1H) combined with tacrolimus in intestinal and multivisceral transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.3.295

The future of organ transplantation: from the laboratory to the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.3.295

Costimulatory blockade prevents early rejection, promotes lymphocyte apoptosis, and inhibits the upregulation of intragraft interleukin-6 in an orthotopic liver transplant model in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.3.295

10.1517/13543784.14.3.295

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference